| 97 |
Dong-A ST Signs Sales and Supply Agreement with Parmir Therapeutics for In-Vitro Degenerative Brain Disease Diagnostics |
2022-04-21 |
| 96 |
Dong-A ST Broadcasts 2022 Public Hearing of Korean Association of Public Health Doctors on Mediflix |
2022-04-11 |
| 95 |
Dong-A ST’s Motilitone Proven Effective for Four Major Functional Gastrointestinal Disorders |
2022-04-08 |
| 94 |
Dong-A ST Launches GERD Treatment Rabiduo Tab. 20/500mg (sodium bicarbonate) |
2022-04-01 |
| 93 |
Dong-A ST Holds 9th Annual General Shareholders' Meeting |
2022-03-28 |
| 92 |
Dong-A ST Signs MOU with Mezoo and Kosin University Gospel Hospital for Cardiac Diagnosis Center |
2022-03-18 |
| 91 |
Dong-A ST Named 2021 Outstanding Company for Stock Market Disclosure |
2022-03-10 |
| 90 |
Dong-A ST Achieves KRW 30 Billion in Sales for Motilitone and Suganon |
2022-01-25 |
| 89 |
Dong-A ST Signs MOU to Support Osteoporosis Treatment for Vulnerable Groups |
2021-06-15 |
| 88 |
Dong-A ST cooperates with Ildong Pharmaceutical on co-promotion of ‘Dong-A Gaster Tablet’. |
2019-10-01 |
